Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hu7691 free base is an orally active, potent and selective Akt inhibitor with anti-proliferative and neurogenic effects on a variety of neuroblastoma cell lines.Hu7691 free base inhibits Akt1, Akt2, and Akt3 and induces differentiation of neuroblastoma cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 722.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,520.00 | |
50 mg | In stock | $ 1,980.00 |
Description | Hu7691 free base is an orally active, potent and selective Akt inhibitor with anti-proliferative and neurogenic effects on a variety of neuroblastoma cell lines.Hu7691 free base inhibits Akt1, Akt2, and Akt3 and induces differentiation of neuroblastoma cells. |
Targets&IC50 | PKCη:629 nM (IC50), Akt3:28 nM (IC50), ROCK1:354 nM (IC50), p70 S6K:229 nM (IC50), PKA:11 nM (IC50), Akt2:97.5 nM (IC50), Akt1:4.0 nM (IC50), RSK1:756 nM (IC50), AKT1:4.0 nM, AKT2:97.5 nM, AKT3:28 nM, mTOR (p70S6K):229 nM, PKA:11 nM, PKCη:629 nM, ROCK1:354 nM, RSK1:756 nM |
In vitro | In HaCaT cells, Hu7691 free base (2.25, 4.5, 9, 18, 36 μM; 24 hours) effectively induces a decrease in the phosphorylation level of Akt (S473)[1]. |
In vivo | In Balb/c mice (nu/nu, female, 3-4 weeks old, 20-25 g), Hu7691 free base (12.5, 25, 50 mg/kg; oral; once daily for 22 days) exhibited dose-dependent inhibition of tumor growth[1]. |
Molecular Weight | 414.423 |
Formula | C22H21F3N4O |
CAS No. | 2241232-43-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hu7691 free base 2241232-43-7 Cytoskeletal Signaling PI3K/Akt/mTOR signaling Akt Hu-7691 free base Hu7691 inhibitor inhibit